journal article·2026-07-01Open access

CPP–PEG‐Guided Surface Engineering of Mitochondria Enables Efficient Cellular Uptake and Respiratory Modulation

Masahiro Shiraishi, Yukari Muramatsu, Akihiro Nakaya, Yuji Maruo, Rick C. Tsai, Masashi Suganuma, Hisashi Ohta, Atsuhito Takeda, Hideyoshi Harashima, Yuma Yamada

Abstract

ABSTRACT Mitochondrial transplantation has emerged as a promising strategy for modulating cellular bioenergetics in mitochondrial dysfunction. However, isolated mitochondria suffer from poor stability and limited cellular uptake, restricting their therapeutic application. To address these limitations, we developed a surface engineering strategy that stabilizes isolated mitochondria while enabling interactions with target cells, providing a platform for selective organ‐ and cell‐targeting. Polyethylene glycol (PEG) with lipid/carbon chains was introduced to mitochondria‐associated membrane structures, forming a protective hydration layer on the mitochondrial surface. This PEG layer also serves as a modular platform for functionalization with biomolecules, such as peptides and antibodies, thereby broadening its biomedical applications. In this study, we examined whether mitochondrial function in target cells can be modulated using PEG‐shielded mitochondria functionalized with a cell‐penetrating peptide (CPP) via a maleimide linkage. Our results suggest that CPP‐PEG‐modified mitochondria exhibit efficient cellular internalization and are associated with increased mitochondrial respiratory activity, consistent with intracellular bioenergetic modulation. These findings suggest that spatially controlled presentation of CPP at the terminus of a PEG layer may provide an effective approach for stabilizing isolated mitochondria while modulating intracellular dynamics and functional responses. This surface engineering strategy offers a proof‐of‐concept design framework for mitochondria‐associated engineering and future bioenergetic strategies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Mitochondrial Function and Pathology · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatrics Graduate School of Medicine Hokkaido University Sapporo Japan

Laboratory of Molecular Design of Pharmaceutics Faculty of Pharmaceutical Sciences Hokkaido University Sapporo Japan

LUCA Science Inc. Tokyo Japan

Laboratory For Biological Drug Development Based on DDS Technology Hokkaido University Sapporo Japan

Laboratory for Pharmaceutics of Cell and Organelle Hokkaido University Sapporo Japan

Laboratory of Innovative Nanomedicines Hokkaido University Sapporo Japan

Institute of Vaccine Research and Development (IVReD) Hokkaido University Sapporo Japan

Funding

Japan Science and Technology Agency · Japan Agency for Medical Research and Development

References (41)

Show source-provided references
1. 10.1016/S0140‐6736(11)61305‐610.1016/S0140‐6736(11)61305‐6 ↗
2. 10.3390/ijms2117636510.3390/ijms21176365 ↗
3. 10.1016/j.jtcvs.2017.02.01810.1016/j.jtcvs.2017.02.018 ↗
4. 10.1016/j.mito.2017.03.00410.1016/j.mito.2017.03.004 ↗
5. 10.1007/s10863‐006‐9005‐610.1007/s10863‐006‐9005‐6 ↗
6. 10.1038/1901202b010.1038/1901202b0 ↗
7. 10.1016/j.jneumeth.2005.08.01710.1016/j.jneumeth.2005.08.017 ↗
8. 10.1038/sj.cdd.440203510.1038/sj.cdd.4402035 ↗
9. 10.1111/jcmm.1512010.1111/jcmm.15120 ↗
10. Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration10.1002/advs.201700530 ↗
11. 10.1021/bi035682s10.1021/bi035682s ↗
12. 10.1016/j.jcyt.2013.06.00810.1016/j.jcyt.2013.06.008 ↗
13. 10.1038/s41598‐017‐10870‐510.1038/s41598‐017‐10870‐5 ↗
14. 10.1016/j.trsl.2015.12.00310.1016/j.trsl.2015.12.003 ↗
15. 10.1186/s13046‐019‐1028‐z10.1186/s13046‐019‐1028‐z ↗
16. 10.2147/OTT.S23814310.2147/OTT.S238143 ↗
17. 10.1016/j.bbamem.2007.11.00210.1016/j.bbamem.2007.11.002 ↗
18. 10.1016/j.jconrel.2014.03.05810.1016/j.jconrel.2014.03.058 ↗
19. A Method for Screening Mitochondrial Fusogenic Envelopes for Use in Mitochondrial Drug Delivery10.1007/978-1-4939-0363-4_2 ↗
20. 10.1016/j.jconrel.2017.11.02410.1016/j.jconrel.2017.11.024 ↗
21. 10.1038/s41598‐022‐08583‐510.1038/s41598‐022‐08583‐5 ↗
22. 10.1016/j.jconrel.2024.01.05810.1016/j.jconrel.2024.01.058 ↗
23. 10.1248/bpb.b24‐0028410.1248/bpb.b24‐00284 ↗
24. 10.1016/j.xphs.2024.01.02010.1016/j.xphs.2024.01.020 ↗
25. 10.1016/j.xphs.2019.04.00110.1016/j.xphs.2019.04.001 ↗
26. 10.1016/j.jconrel.2015.06.03710.1016/j.jconrel.2015.06.037 ↗
27. 10.1038/s41598‐020‐64322‐810.1038/s41598‐020‐64322‐8 ↗
28. 10.1016/j.mito.2019.08.00410.1016/j.mito.2019.08.004 ↗
29. 10.1016/j.omtn.2020.04.00410.1016/j.omtn.2020.04.004 ↗
30. 10.3390/ijms2508429410.3390/ijms25084294 ↗
31. 10.1248/bpb.b25‐0021810.1248/bpb.b25‐00218 ↗
32. 10.1021/bc015508l10.1021/bc015508l ↗
33. 10.1016/S0142‐9612(00)00193‐910.1016/S0142‐9612(00)00193‐9 ↗
34. Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential
35. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
36. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
37. 10.1016/j.jconrel.2011.03.01210.1016/j.jconrel.2011.03.012 ↗
38. 10.1208/s12248‐012‐9330‐010.1208/s12248‐012‐9330‐0 ↗
39. 10.1016/j.jconrel.2020.09.05510.1016/j.jconrel.2020.09.055 ↗
40. 10.1038/s42255‐024‐01125‐510.1038/s42255‐024‐01125‐5 ↗
41. 10.1002/smmd.13410.1002/smmd.134 ↗